The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer
Abstract CINSARC, a multigene expression signature originally developed in sarcomas, was shown to have prognostic impact in various cancers. We tested the prognostic value for disease-free survival (DFS) of CINSARC in a series of 6035 early-stage invasive primary breast cancers. CINSARC had independ...
Enregistré dans:
| Auteurs principaux: | Anthony Goncalves, Pascal Finetti, Daniel Birnbaum, François Bertucci |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/ecafbdc5cfd6482fbd26fa13182d387e |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer
par: Andrea Gombos, et autres
Publié: (2021) -
Hyperleptinemia in obese state renders luminal breast cancers refractory to tamoxifen by coordinating a crosstalk between Med1, miR205 and ErbB
par: Arumugam Nagalingam, et autres
Publié: (2021) -
Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer
par: Amanda Bortolini Silveira, et autres
Publié: (2021) -
A genomic mutation signature predicts the clinical outcomes of immunotherapy and characterizes immunophenotypes in gastrointestinal cancer
par: Xi Jiao, et autres
Publié: (2021) -
Spatial distribution of B cells and lymphocyte clusters as a predictor of triple-negative breast cancer outcome
par: Juliana C. Wortman, et autres
Publié: (2021)